Your Health 5-13-13 - ABC 33/40 - Birmingham News, Weather, Sports

Your Health 5-13-13 New COPD treatment

Posted: Updated:

    The U.S. Food and Drug Administration has approved a new drug to treat a lung disease that is the third leading cause of death among Americans.
       The agency gave the green light for the drug, Breo Ellipta to treat chronic obstructive pulmonary disease, also known as COPD.
    It's approved to for use among patients with COPD, including chronic bronchitis and/or emphysema.
       The FDA says the drug works by decreasing airflow in the lungs and helping muscles around the airways of the lungs stay relaxed in order to increase airflow.
     Serious side effects associated with the drug include increased risks of pneumonia and bone fractures.
     The most common side effects include inflammation of the nasal passage, upper respiratory tract infection, and headache.

Most Popular